SEC 13F Intelligence

Managers / Q1 2026

Cannon Global Investment Management, LLC

CIK 0001844427 · 12555 ORANGE DR., 274, DAVIE, FL, 33330 · 754-2169588

Reported Value
$51M
Q1 2026
Positions
82
Filings on Record
22
2021–present window
Filed
Apr 21, 2026
original filing

Summary

Cannon Global Investment Management, LLC reported $51M in U.S.-listed holdings across 82 positions for Q1 2026.

Its largest position, NSC, represents 3.9% of the portfolio.

Compared with Q4 2025, the fund opened 49 new positions and exited 27.

Portfolio Metrics

Turnover
+50.2%
vs prior filed quarter
Top-10 Concentration
+25.5%
share of reported value
Largest Position
+3.9%
Norfolk Southn
New / Exited
49 / 27
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’20: $8MQ4 ’20Q1 ’21: $59MQ2 ’21: $51MQ3 ’21: $67MQ3 ’21Q4 ’21: $63MQ1 ’22: $139MQ2 ’22: $6MQ2 ’22Q3 ’22: $62MQ4 ’22: $67MQ1 ’23: $0Q1 ’23Q2 ’23: $19MQ3 ’23: $14MQ4 ’23: $13MQ4 ’23Q1 ’24: $37MQ2 ’24: $21MQ3 ’24: $63MQ3 ’24Q4 ’24: $46MQ1 ’25: $57MQ2 ’25: $49MQ2 ’25Q3 ’25: $67MQ4 ’25: $40MQ1 ’26: $51MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 64.3%ETP: 16.1%Other: 14.8%REIT: 2.9%ADR: 1.3%Other: 0.5%
  • Common Stock · 64.3% · $33M
  • ETP · 16.1% · $8M
  • Other · 14.8% · $8M
  • REIT · 2.9% · $1M
  • ADR · 1.3% · $668,100
  • Other · 0.5% · $253,629

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
QQQINVESCO QQQ TRNEW+13.0K13.0K+$8M$8M
TERNS PHARMACEUTICALS INCNEW+34.0K34.0K+$2M$2M
SUISUN CMNTYS INCNEW+11.9K11.9K+$1M$1M
QGENQIAGEN NVNEW+34.4K34.4K+$1M$1M
RVMDREVOLUTION MEDICINES INCNEW+8.5K8.5K+$826,625$826,625
ALNYALNYLAM PHARMACEUTICALS INCNEW+2.4K2.4K+$794,088$794,088
ESTAESTABLISHMENT LABS HLDGS INCNEW+13.0K13.0K+$738,140$738,140
CLBTCELLEBRITE DI LTDNEW+52.5K52.5K+$723,450$723,450

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

79 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1NSCNORFOLK SOUTHN CORPhistory →COM3.92%$2M7.0K
2SUISUN CMNTYS INChistory →COM2.93%$1M11.9K
3LNGCHENIERE ENERGY INChistory →COM NEW2.83%$1M5.1K
4QGENQIAGEN NVhistory →ORD SHARES2.69%$1M34.4K
5ZMZOOM COMMUNICATIONS INChistory →CL A2.56%$1M16.3K
6CANTOR EQUITY PARTNERS I INCSHS CL A2.42%$1M118.0K
7EAELECTRONIC ARTS INChistory →COM2.39%$1M6.0K
8FOXFOX CORPhistory →CL B COM1.99%$1M19.2K
9MRVLMARVELL TECHNOLOGY INChistory →COM1.90%$970,6909.8K
10CANTOR EQUITY PARTNERS II INCL A ORD SHS1.87%$958,32088.0K
11RENATUS TACTICAL ACQUISSHS CL A1.86%$952,95692.7K
12SSNCSS&C TECH HLDGShistory →COM1.85%$945,98014.0K
13CANTOR EQUITY PARTNERS III ISHS CL A1.69%$863,97883.8K
14RVMDREVOLUTION MEDICINES INChistory →COM1.61%$826,6258.5K
15GTLSCHART INDS INChistory →COM1.57%$806,3253.9K
16ALNYALNYLAM PHARMACEUTICALS INChistory →COM1.55%$794,0882.4K
17CANTOR EQUITY PARTNERS IV INSHS CL A1.51%$771,38375.7K
18BPOPPOPULAR INChistory →COM NEW1.49%$764,7695.7K
19ESTAESTABLISHMENT LABS HLDGS INChistory →COM1.44%$738,14013.0K
20CLBTCELLEBRITE DI LTDhistory →ORDINARY SHARES1.41%$723,45052.5K
21FERGFERGUSON ENTERPRISES INChistory →COMMON STOCK NEW1.37%$699,7803.0K
22ABVXABIVAX SAhistory →SPONSORED ADS1.30%$668,1006.0K
23FROGJFROG LTDhistory →ORD SHS1.29%$661,71314.1K
24UNFUNIFIRST CORP MASShistory →COM1.23%$628,9752.5K
25WBDWARNER BROS DISCOVERY INChistory →COM SER A1.21%$617,85022.5K
26HNGEHINGE HEALTH INChistory →CL A1.20%$613,10415.9K
27HENNESSY CAP INVT CORP VIIORD SHS CL A1.17%$600,30058.0K
28CHYMCHIME FINL INChistory →COM SHS CL A1.13%$580,70531.0K
29KNSAKINIKSA PHARMACEUTICALS INTLhistory →ORD SHS CL A1.03%$529,65011.0K
30PENPENUMBRA INChistory →COM1.03%$525,3921.6K
31JBLUJETBLUE AIRWAYS CORPhistory →COM1.02%$521,560118.0K
32SUNBSUNBELT RENTALS HOLDINGS INChistory →SHS1.02%$520,7208.0K
33CLEARWATER ANALYTICS HLDGS ICL A0.97%$494,28520.9K
34TRIPTRIPADVISOR INCCOM0.96%$492,49246.2K
35TERNS PHARMACEUTICALS INCCOM0.93%$474,4809.0K
36CTMXCYTOMX THERAPEUTICS INC.COM0.88%$451,67096.1K
37DNTHDIANTHUS THERAPEUTICS INCCOM0.84%$427,9925.1K
38BERTO ACQUISITION CORPORD SHS0.83%$427,42541.7K
39MDGLMADRIGAL PHARMACEUTICALS INCCOM0.82%$418,776800
40GFLGFL ENVIRONMENTAL INCSUB VTG SHS0.81%$417,20010.0K
41MNROMONRO INCCOM0.80%$409,02025.5K
42STAASTAAR SURGICAL COCOM PAR $0.010.80%$407,66021.8K
43IBITISHARES BITCOIN TRUST ETFSHS BEN INT0.80%$407,25210.6K
44LWLGLIGHTWAVE LOGIC INCCOM0.76%$386,65055.0K
45DLOCAL LTDCLASS A COM0.71%$361,86327.9K
46BWBABCOCK & WILCOX ENTERPRISESCOM0.70%$359,90524.5K
47RONBBARON ETF TRFIRST PRINCIPLES0.70%$356,77215.6K
48RNAATRIUM THERAPEUTICS INCCOM0.66%$335,41325.1K
49RDDTREDDIT INCCL A0.63%$323,1602.4K
50BHFBRIGHTHOUSE FINL INCCOM0.58%$299,4005.0K
51BOLD EAGLE ACQUISITION CORPCL A0.58%$298,70628.3K
52ULSUL SOLUTIONS INCCLASS A COM SHS0.57%$291,4143.4K
53SPRING VY ACQUISITION CORP ISHS CL A0.55%$279,40027.5K
54MDLNMEDLINE INCCOM CL A0.52%$267,0006.0K
55HOLOGIC INCCOM0.52%$264,5653.5K
56CZRCAESARS ENTERTAINMENT INC NECOM0.52%$264,30010.0K
57TBPHTHERAVANCE BIOPHARMA INCCOM0.51%$260,44316.0K
58PAYPAYMENTUS HOLDINGS INCCOM CL A0.50%$256,54010.1K
59BCRXBIOCRYST PHARMACEUTICALS INCCOM0.49%$253,23226.6K
60DMRADAMORA THERAPEUTICS INCCOM NEW0.47%$240,8709.3K
61GDENGOLDEN ENTMT INCCOM0.46%$234,8728.8K
62BF/BBROWN FORMAN CORPCL B0.45%$232,6728.8K
63GME/WSGAMESTOP CORP NEW*W EXP 10/30/2020.43%$221,57057.4K
64IVVDINVIVYD INCCOM0.41%$209,300161.0K
65VORVOR BIOPHARMA INCCOM NEW0.41%$208,72811.7K
66QUREUNIQURE NVSHS0.39%$199,47012.2K
67DIGITAL ASSET ACQUISITION COSHS CL A0.39%$198,65619.4K
68CRESCENT BIOPHARMA INC.COM0.37%$187,37410.2K
69GP-ACT III ACQUISITION CORPCL A0.35%$181,02816.7K
70CTNMCONTINEUM THERAPEUTICS INCCL A0.33%$169,78013.0K
71LAUNCH TWO ACQUISITION CORP.ORD SHS CL A0.26%$133,81212.6K
72OCGNOCUGEN INCCOM0.25%$126,70070.0K
73KDKKODIAK AI INC.COM0.23%$119,36817.2K
74KENNEDY-WILSON HOLDINGS INCCOM0.22%$113,61010.5K
75IPSCCENTURY THERAPEUTICS INCCOM0.22%$110,74049.0K
76FOSLFOSSIL GROUP INCCOM0.22%$110,33625.6K
77NERVMINERVA NEUROSCIENCES INCCOM NEW0.21%$106,99217.8K
78OBIOORCHESTRA BIOMED HLDGS INCCOM0.19%$96,08022.6K
79GENVRGEN DIGITAL INCRIGHT 99/99/99990.06%$32,05968.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$51M82Apr 21, 202613F-HRchanges · EDGAR ↗
Q4 2025$40M59Jan 27, 202613F-HRchanges · EDGAR ↗
Q3 2025$67M65Oct 28, 202513F-HRchanges · EDGAR ↗
Q2 2025$49M68Jul 29, 202513F-HRchanges · EDGAR ↗
Q1 2025$57M78Apr 28, 202513F-HRchanges · EDGAR ↗
Q4 2024$46M71Feb 11, 202513F-HRchanges · EDGAR ↗
Q3 2024$63M66Oct 29, 202413F-HRchanges · EDGAR ↗
Q2 2024$21M35Aug 2, 202413F-HRchanges · EDGAR ↗
Q1 2024$37M62Apr 17, 202413F-HRchanges · EDGAR ↗
Q4 2023$13M23Jan 31, 202413F-HRchanges · EDGAR ↗
Q3 2023$14M27Oct 19, 202313F-HRchanges · EDGAR ↗
Q2 2023$19M35Jul 20, 202313F-HRchanges · EDGAR ↗
Q1 2023$01May 10, 202313F-HRchanges · EDGAR ↗
Q4 2022$67M25Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$62M28Nov 2, 202213F-HRchanges · EDGAR ↗
Q2 2022$6M2Aug 4, 202213F-HRchanges · EDGAR ↗
Q1 2022$139M99May 2, 202213F-HRchanges · EDGAR ↗
Q4 2021$63M38Feb 4, 202213F-HRchanges · EDGAR ↗
Q3 2021$67M49Oct 27, 202113F-HRchanges · EDGAR ↗
Q2 2021$51M41Aug 3, 202113F-HRchanges · EDGAR ↗
Q1 2021$59M92May 6, 202113F-HRchanges · EDGAR ↗
Q4 2020$8M6Feb 11, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.